课题基金 / 基金详情

Clinical Cancer Genetics Community Network: A Sustainable Research Partnership

Clinical Cancer Genetics Community Network: A Sustainable Research Partnership
临床癌症遗传学社区网络:可持续的研究合作伙伴关系
批准号:
8008599
负责人:
JEFFREY N WEITZEL
金额:
$100.0万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-08-09 至 2013-07-31

项目摘要

项目成果

JEFFREY N WEITZEL的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): With dramatic advances in the understanding of the genetic basis of cancer over the past decade, genetic cancer risk assessment (GCRA) has emerged as a distinct clinical consultative service. GCRA utilizes rapidly evolving genetic technologies along with established empiric risk models to estimate cancer risk and to provide age- and risk-level appropriate cancer prevention and risk-reduction strategies for individuals and their families. Despite clinical studies documenting the efficacy of cancer risk reduction measures in high-risk individuals, there is still very limited access to GCRA services for the underserved, underinsured, and many ethnic minorities. To address this need, the City of Hope (COH) Comprehensive Cancer Center developed a Cancer Screening & Prevention Program Network (CSPPN) to facilitate the delivery of state of the art GCRA services in both local and distant communities. Growth of the CSPPN was enabled by information technology, with videoconferencing for telemedicine and web conferencing for remote participation in multidisciplinary genetics tumor boards. An innovative clinician education program also catalyzed expansion of an affiliated clinical cancer genetics community network (CCGCN), which has accrued >6,000 high risk patients, and scholarly research created in collaboration with community partners in the realms of genetic epidemiology, bio- behavioral research, disparities specific behavioral and epidemiological research, and locally-relevant and practical health services research. However, the growth of the CCGCN, as well as the efficiency, quality and ultimately the utility of the prospective registry data are constrained by significant limitations in the current infrastructure. The overall aim of this application is to expand and enhance the quality and integrity of an established community-based national hereditary cancer research registry network to facilitate and accelerate the pace, productivity, dissemination, and translation of research findings to local practice. This will be accomplished through the following Specific Aims: (1) Reconfigure pedigree-drawing and the relational database to facilitate web-based access for community network participants; (2) Establish procedures for the collaborative administration and use of research registry data and biospecimens; (3) Expand and enhance an established cancer genetics community of practice using Academic Health Center (AHC) resources to generate and sustain the participation of community-based clinicians in the research network and (4) Create common and complimentary research agendas, especially among underserved outreach clinics, to address geographic, socioeconomic, and ethnic disparities in cancer genetics healthcare and research participation. The proposed project will serve to further develop academic-community research partnerships, utilizing the developed collaborative research infrastructure to improve and maximize communication among the research community, and more effectively disseminate locally-relevant research findings. PUBLIC HEALTH RELEVANCE: The proposed clinical cancer genetics community network project will serve to further develop academic-community research partnerships, utilizing the developed collaborative research infrastructure to improve and maximize communication among the research communities and more effectively facilitate and initiate community-based research, as well as disseminate locally-relevant research findings.
期刊论文(15)
专著(0)
科研奖励(0)
会议论文
Ingredients for success: a familial cancer clinic in an oncology practice setting.
成功的要素:肿瘤学实践环境中的家族癌症诊所。
DOI: 10.1200/jop.2010.000048
发表时间: 2011
期刊: Journal of oncology practice
影响因子: --
作者: [Duncan,PaulR, Lin,JamesT]
通讯作者: Lin,JamesT
DOI: 10.1016/j.clgc.2023.05.012
发表时间: 2023-05
期刊: Clinical genitourinary cancer
影响因子: 3.2
作者: [Y. Chávarri-Guerra;M. Bourlon;J. L. Rodriguez-Olivares;Luis Orozco;Deborah Bazua;Andrés Rodríguez-Faure;Mirza Jacqueline Alcalde-Castro;E. Castro;D. Castillo;J. Herzog;J. Weitzel]
通讯作者: Y. Chávarri-Guerra;M. Bourlon;J. L. Rodriguez-Olivares;Luis Orozco;Deborah Bazua;Andrés Rodríguez-Faure;Mirza Jacqueline Alcalde-Castro;E. Castro;D. Castillo;J. Herzog;J. Weitzel
A Novel, Likely Pathogenic MAX Germline Variant in a Patient With Unilateral Pheochromocytoma.
单侧嗜铬细胞瘤的患者中,一种新型的,可能的致病性最大种系变体。
DOI: 10.1210/jendso/bvab085
发表时间: 2021-08-01
期刊: Journal of the Endocrine Society
影响因子: 4.1
作者: [Lam-Chung CE, Rodríguez LL, Vázquez JA, Chávarri-Guerra Y, Arízaga-Ramírez R, Antonio OF, De Anda González J, López-Hernández MA, Weitzel JN, Castillo D, Gómez-Pérez FJ, Cuevas-Ramos D]
通讯作者: Cuevas-Ramos D
DOI: 10.1371/journal.pone.0037891
发表时间: 2012
期刊: PloS one
影响因子: 3.7
作者: [Pilarski R, Patel DA, Weitzel J, McVeigh T, Dorairaj JJ, Heneghan HM, Miller N, Weidhaas JB, Kerin MJ, McKenna M, Wu X, Hildebrandt M, Zelterman D, Sand S, Shulman LP]
通讯作者: Shulman LP
9
    Novel targeted therapies for BRCA-associated cancer
    Novel targeted therapies for BRCA-associated cancer
    Community Cancer Genetics and Research Training (Revision)
    Hereditary Breast Cancer and Novel Hispanic BRCA Mutations
    海外基金